Hydrogel-based wound dressings for controlled curcumin release
Innovative hydrogel-based wound dressings from terpolymer materials enable controlled release of curcumin, enhancing wound healing by modulating inflammation and supporting tissue regeneration. These dressings are cost-effective, versatile, and clinically promising.
Overview
Introducing a next-generation wound dressing solution utilizing hydrogel-based terpolymer materials designed for the controlled release of curcumin. Curcumin is a renowned antioxidant and anti-inflammatory agent that can significantly aid in wound healing and tissue regeneration. Our innovative wound dressings not only modulate inflammation but also support skin tissue regeneration, making them ideal for various wound types. The materials are inexpensive, translucent, and can be molded into different shapes, facilitating easy clinical translation and application.
Technical specifications
Key features:
- Controlled release of curcumin: Ensures sustained delivery over months, leveraging curcumin's full therapeutic potential.
- High water content (40%): Promotes a moist wound environment conducive to healing.
- Versatile formability: Can be easily shaped into various bandage types to suit different wound applications.
- Transparency: Allows visualization of the wound bed for monitoring healing progress.
- Cost-effective production: Utilizes inexpensive terpolymer materials, making it accessible for widespread use.
Technology readiness level
This technology is currently at Technology Readiness Level 3, having demonstrated proof-of-concept with controlled curcumin release. Further development will involve collaboration to optimize the material shapes and encapsulate additional therapeutic molecules. Future studies will include preclinical testing in murine models and assessments of effects on human cells, paving the way for clinical application.
About Queen's University
Queen’s University is a comprehensive public research institution with a large student body and global alumni network based in Kingston, Ontario. For industry, it offers a research and technology park with wet/dry labs, shared core facilities, and collaboration models from sponsored research to contract testing. Clinical translation is enabled by integration with Kingston’s major hospital system, providing governed access to patients, clinicians, and health data. Talent pipelines are built through structured internship programs and project-based engagements. Research is backed by Canada’s Tri‑Council agencies and the Canada Foundation for Innovation, plus provincial and industry support, and a dedicated tech transfer office advances IP, licensing, and startups.
delivered to your inbox.